| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 853-855 |
| Número de páginas | 3 |
| Publicación | JACC: Cardiovascular Interventions |
| Volumen | 11 |
| N.º | 9 |
| DOI | |
| Estado | Published - may 14 2018 |
Financiación
No randomized trial comparing HCR with multivessel PCI has been completed, but there is an ongoing, ∼2,400-patient, multicenter, randomized trial funded by the National Heart, Lung, and Blood Institute ( NCT03089398 ). Pending these results, HCR may yet become a more commonly used third interventional strategy for certain patients with multivessel CAD.
| Financiadores | Número del financiador |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | NCT03089398 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Huella
Profundice en los temas de investigación de 'Hybrid Coronary Revascularization 5 Years On: Is Clinical Equipoise Good Enough? ∗'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver